The role of nitric oxide in oral diseases

被引:77
作者
Brennan, PA
Thomas, GJ
Langdon, JD
机构
[1] Queen Alexandra Hosp, Dept Maxillofacial & Head & Neck Surg, Portsmouth PO6 3LY, Hants, England
[2] UCL Eastman Dent Inst, Dept Oral Pathol, London WC1X 8LD, England
[3] Kings Coll London, Sch Med & Dent, Maxillofacial Dept, London SE5 8RX, England
关键词
nitric oxide; review; oral disease; cancer;
D O I
10.1016/S0003-9969(02)00183-8
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Although previously regarded as a toxic pollutant gas, nitric oxide (NO) is a short-lived molecule that plays a key role in many physiological and pathological processes. It is produced in vivo from the amino acid L-arginine by a complex family of enzymes termed nitric oxide synthase (NOS). Since its discovery as a biological messenger in 1987, NO has been implicated in many disease processes, ranging from septic shock to cancer. It is a highly reactive free radical and causes concentration-dependent conformational. changes in proteins, enzymes and DNA, predominantly by its reaction with transition metals and thiol. residues. Although high concentrations of NO are cytotoxic, the levels, produced in many human cancers possibly facilitate tumour growth and dissemination. The interest in this molecule by scientists and clinicians involved with the oral cavity and head and neck regions is fairly recent, and only a tiny minority of 50,000 papers currently cited on NO relate to diseases in this anatomical area. This review gives an overview of NO, outlining its basic chemistry, formation by NOS and its possible roles in the oral. diseases studied to date. The implications for possible therapeutic maniputation of NO are also discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 60 条
  • [1] NITRIC-OXIDE SYNTHASES REVEAL A ROLE FOR CALMODULIN IN CONTROLLING ELECTRON-TRANSFER
    ABUSOUD, HM
    STUEHR, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10769 - 10772
  • [2] Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53
    Ambs, S
    Bennett, WP
    Merriam, WG
    Ogunfusika, MO
    Oser, SM
    Khan, MA
    Jones, RT
    Harris, CC
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 233 - 239
  • [3] The possible role of nitric oxide in the physiopathology of pain associated with temporomandibular joint disorders
    Anbar, M
    Gratt, BM
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1998, 56 (07) : 872 - 882
  • [4] Bentz BG, 1998, HEAD NECK-J SCI SPEC, V20, P304, DOI 10.1002/(SICI)1097-0347(199807)20:4<304::AID-HED4>3.0.CO
  • [5] 2-2
  • [6] Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck
    Bentz, BG
    Haines, GK
    Lingen, MW
    Pelzer, HJ
    Hanson, DG
    Radosevich, JA
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1999, 108 (08) : 781 - 787
  • [7] Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia
    Brennan, PA
    Conroy, B
    Spedding, AV
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2000, 90 (05): : 624 - 629
  • [8] Are myoepithelial cells responsible for the widespread expression of inducible nitric oxide synthase in pleomorphic adenoma? An immunohistochemical study
    Brennan, PA
    Umar, T
    Zaki, GA
    Langdon, JD
    Spedding, A
    Buckley, J
    Downie, IP
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (06) : 279 - 283
  • [9] Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia
    Brennan, PA
    Umar, T
    Wilson, AW
    Mellor, TK
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2002, 60 (12) : 1455 - 1460
  • [10] Brennan PA, 2001, HEAD NECK-J SCI SPEC, V23, P217, DOI 10.1002/1097-0347(200103)23:3<217::AID-HED1021>3.0.CO